SonaCare Medical achieves a successful pilot using the Company's new remote monitoring software, Sonalink™.

CHARLOTTE, N.C., FEBRUARY 10, 2016 -- SonaCare Medical, LLC reports the introduction of a highly anticipated expansion to their comprehensive training and support program, Sonalink™ remote monitoring. The inaugural launch of this new technology occurred over the course of two Sonablate® HIFU procedures performed on Friday, February 5th, connecting Dr. Samuel Peretsman to a HIFU technical expert at SonaCare Medical headquarters.

Dr. Lepor becomes first urologist in the Northeast to perform the newly authorized Sonablate prostate tissue ablation procedure.

CHARLOTTE, N.C., JANUARY 26, 2016 -- SonaCare Medical, LLC announces that Drs. Herbert Lepor and James Wysock performed a HIFU Sonablate prostate tissue ablation procedure in New York City last week, making them the first physicians to use the device in the Northeast since Sonablate® received FDA clearance in October 2015.

Dr. Peretsman launches his U.S.-based prostate High Intensity Focused Ultrasound (HIFU) program in Huntersville, North Carolina by performing two HIFU procedures on the same day.

CHARLOTTE, N.C., JANUARY 13, 2016 -- SonaCare Medical, LLC announces the completion of two Sonablate® prostate tissue ablations performed by Dr. Samuel Peretsman. Both procedures were completed on Friday January 8th, 2016.

Physicians across the United States are adopting Sonablate® as the preferred prostate tissue ablation device.

CHARLOTTE, N.C., January 5, 2016 -- SonaCare Medical, LLC, a pioneer in minimally invasive high intensity focused ultrasound (HIFU) technologies, and first to receive FDA regulatory authorization for the ablation of prostate tissue, reports impressive Q4 growth in 2015 since receiving a de novo grant from the Food and Drug Administration (FDA) to market and sell Sonablate® in the United States in October, 2015.

SonaCare Medical HIFU device, Sonablate®, used by both Dr. Tracy Gapin and Dr. Stephen Scionti in Sarasota

CHARLOTTE, N.C., DECEMBER 17, 2015 - SonaCare Medical, LLC, industry leader in minimally invasive high intensity focused ultrasound (HIFU) technologies, is pleased to report that Dr. Tracy Gapin has begun delivering prostate ablations at the Sarasota Interventional Radiology Treatment Center (SIR). Dr. Gapin performed his first U.S. Sonablate® procedure at SIR earlier this week, on December 15th, with guidance from Stephen Scionti, MD.

SonaCare Medical's HIFU device is used by Dr. Kar in first Sonablate® procedure at the miVIP Surgery Center, the fifth location in the United States to perform a HIFU prostate tissue ablation with Sonablate post FDA clearance

Charlotte, NC (PRWEB) December 15, 2015 -- SonaCare Medical, LLC, the leading manufacturer of urologic HIFU technology and the first to receive FDA regulatory authorization for the ablation of prostate tissue, has announced the fifth location in the United States to perform a Sonablate® procedure post FDA clearance. The miVIP Surgery Center, in Tustin, California, installed Sonablate® in mid-November and its leading physician, Dr. Ashok Kar, performed the center’s first U.S.-based prostate tissue ablation procedure this past weekend on December 12th.

HIFU company

Latest News

17 May 2018

SonaCare Medical congratulates Naren Sanghvi on his receipt of The William and Francis Fry Honorary Fellowship for Contributions to Therapeutic Ultrasound

10 April 2018

Over 120 urologists gather at Imperial College London to learn new diagnostic techniques and minimally invasive focal approaches for treating prostate cancer.